Coxibs and cardiovascular risk
- PMID: 16217098
- PMCID: PMC1247685
- DOI: 10.1503/cmaj.1050119
Coxibs and cardiovascular risk
Comment on
-
New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).CMAJ. 2005 May 10;172(10):1299. doi: 10.1503/cmaj.050456. Epub 2005 Apr 15. CMAJ. 2005. PMID: 15833921 Free PMC article. No abstract available.
Similar articles
-
Raising the safety bar--the FDA's coxib meeting.N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055. N Engl J Med. 2005. PMID: 15800221 No abstract available.
-
Arthritis medicines and cardiovascular events--"house of coxibs".JAMA. 2005 Jan 19;293(3):366-8. doi: 10.1001/jama.293.3.366. Epub 2004 Dec 28. JAMA. 2005. PMID: 15623849 No abstract available.
-
Tailoring arthritis therapy in the wake of the NSAID crisis.N Engl J Med. 2005 Jun 23;352(25):2578-80. doi: 10.1056/NEJMp058105. N Engl J Med. 2005. PMID: 15972863 No abstract available.
-
[Celecoxib].Dtsch Med Wochenschr. 2002 Apr 12;127(15):803-4. doi: 10.1055/s-2002-25051. Dtsch Med Wochenschr. 2002. PMID: 11951138 Review. German. No abstract available.
-
Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?J Pain Palliat Care Pharmacother. 2006;20(4):11-32. J Pain Palliat Care Pharmacother. 2006. PMID: 17182503 Review.
References
-
- Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA 2000;284:1247-55. - PubMed
-
- Food and Drug Administration. Celebrex capsules (Celecoxib). Medical Officer Review. 14-6-2000. Available: www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_03_med.pdf (accessed 2005 June 1).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical